Wellington Management Group’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-647
Closed -$693K 1959
2019
Q4
$693K Buy
647
+129
+25% +$132K ﹤0.01% 1794
2019
Q3
$479K Sell
518
-445
-46% -$489K ﹤0.01% 1881
2019
Q2
$1.09M Buy
963
+687
+249% +$752K ﹤0.01% 1745
2019
Q1
$374K Buy
+276
New +$374K ﹤0.01% 1947
2018
Q2
Sell
-1,815
Closed -$2.1M 2263
2018
Q1
$2.1M Sell
1,815
-221
-11% -$291K ﹤0.01% 1720
2017
Q4
$2.41M Sell
2,036
-1,551
-43% -$1.94M ﹤0.01% 1676
2017
Q3
$4.82M Sell
3,587
-1,096
-23% -$1.15M ﹤0.01% 1485
2017
Q2
$3.78M Buy
4,683
+1,202
+35% +$837K ﹤0.01% 1512
2017
Q1
$2.15M Buy
3,481
+1,244
+56% +$758K ﹤0.01% 1722
2016
Q4
$1.2M Sell
2,237
-1,164
-34% -$581K ﹤0.01% 1814
2016
Q3
$1.76M Sell
3,401
-2,897
-46% -$1.36M ﹤0.01% 1677
2016
Q2
$2.58M Buy
6,298
+2,826
+81% +$1.29M ﹤0.01% 1543
2016
Q1
$1.85M Buy
+3,472
New +$1.73M ﹤0.01% 1625

Other funds holding KYNB

Wellington Management Group's KYNB Position: Q1 2020 in Review

Wellington Management Group sold out of Kyntra Bio (KYNB) in Q1 2020, closing a stake of 647 shares — an estimated $693K sold.

Wellington Management Group first reported a position in KYNB in Q1 2016 and held it in 13 quarters. The position peaked at $4.82M in Q3 2017. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

  • Wellington Management Group reported no remaining Kyntra Bio position as of Q1 2020 after selling out during the quarter.
  • Wellington Management Group sold 647 Kyntra Bio shares in Q1 2020, an estimated $693K.
  • Wellington Management Group first reported a position in Kyntra Bio in Q1 2016 and held it in 13 quarters.
  • Wellington Management Group's Kyntra Bio position peaked at $4.82M in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.